1Weiss R, Scheiblhofer S, Freund J, et al.Gene gun bombardment with gold particles displays a particular Th2-promoting signal that over-rules the Th 1-inducing effect of immunostimulatory CpG motifs in DNA vaccines. Vaccine, 2002, 20(25 - 26): 3148 - 3154
2Lin CM, Tan Y, Lee YM, et al. Expression of human phenylalanine hydroxylase activity in T lymphoeytes of classical phenylketonuria children by retroviral-mediated genetransfer. J Inherit Metab Dis, 1997,20(6) :742 - 754
3Nair SK, Boczkowski D, Morse M, et al. Inducton of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nature Biotech, 1998, 16(4): 364 -369
4Sizemore DR, Branstrom AA, Sadoff JC. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine, 1997,15(8) :804 - 807
5Darji A, Zur Lage S, Garbe AI, et al. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunology and Medical Microbiology. FEMS Immunol Med Microbiol, 2000,27 (4): 341 -349
6Masayuki Y. Gene delivery using temperatureresponsive polymeric carriers. Drug Delivery Today, 2002,7(7): 426 - 433
7Takuji M, Howard SA, Koichi M. Osteogenic protein-1 gene: gene gun transfer to intervertebral disc cells. The Spine Journal, 2002, 2(2 Suppl 1): 16-17
8During MJ, Xu R, Young D, et al. Peroral gene therapy of lactose intolerance using an adeno - associated virus vector. Nat Med,1998, 4(10):1131 - 1135
9MacLaughlin FC, Mumper R J, Wang J, et al. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. Control Release, 1998,56( 1 - 3): 259 - 272
10Fang B, Eisensmith RC, Li XH, et al. Gene therapy for hynylketonuria: pheno-typic correction in a genetically decient mouse model by adenovirus-mediated hepatic gene transfer.Gene Ther, 1994,1 (4) :247 - 254
2Shyu K G,Wang M T,Wang B W,et al.Intramyocardial injection of naked DNA encoding HIF-1alpha/VPI6 hybrid to enhance angiogenesis in an acute myocardial infarction model in the rat[J].Cardiovasc Res,2002,54(3):576-583.
3Rajagopalan S,Olin J,Deitcher S.et al.Use of a constitutively active hypoxia-indueible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients:phase Ⅰ doseescalation experience[J].Circulation,2007,115 (10):1234-1243.
4Tongers J,Roncalli J G,Losordo D W.Therapeutic angiogenesis for critical limb ischemia:microvascular therapies coming of age[J].Circulation,2008,118 (1):9-16.
5Vincent K A,Shyu K G,Luo Y,et al.Angiogenesis is induced in a rabbit model of hindlimb ischemia by naked DNA encoding an HIF-1alpha/VP16 hybrid transcription factor[J].Circulation,2000,102 (18):2255-2261.
